# Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

> **NCT01625702** · NA · COMPLETED · sponsor: **Peking University** · enrollment: 138 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DEVICE:** CellSearch® CTC kit

## Key facts

- **NCT ID:** NCT01625702
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-07
- **Final completion:** 2015-12
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625702, "Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01625702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*